Objective: A case of anticholinergic delirium in a female adolescent is described, exploring the pharmacokinetic reasons for the prolonged time course and reviewing the management provided.
Conclusion: A 14 year old female hospitalised for depression ingested large quantities of promethazine and cyproheptadine. A severe anticholinergic delirium ensued which resolved after six days, much longer than the expected duration. The likely cause of the prolonged delirium was the interaction of promethazine and fluvoxamine through the inhibition of the CYP2D6 enzyme. The patient's young age, the severity of the poisoning and the use of drugs with anticholinergic properties to manage the delirium may also have contributed. The delirium may have been reversed had a cholinesterase inhibitor been provided soon after the overdose.
BurnsMJLindenCHGraudinsABrownRMFletcherKE. A comparison of physostigmine and benzodiazepines for the treatment of anticholinergic poisoning. Annals of Emergency Medicine.2000; 35: 374–381.
2.
LeakDCarrollD. Promethazine poisoning: Clinical and electroencephalographic observations. British Medical Journal.1967; 2: 31–32.
3.
RichmondMSegerD. Central anticholinergic syndrome in a child: A case report. The Journal of Emergency Medicine.1985; 3: 453–456.
4.
BaehrGRomanoMYoungJ. An unusual case of cyproheptadine (Periactin) overdaose in an adolescent female. Paediatric Emergency Care.1985; 2: 183–185.
5.
BlausteinB.GaetaT.BalentineJ.GindiM. Cyproheptadine-induced central anticholinergic syndrome in a child: A case report. Paediatric Emergency Care.1995; 11: 235–237.
6.
NakamuraKYokoiTInoueKShimadaN. CYP2D6 is the principal cytochrome P450 responsible for metabolism of the histamine H1 antagonist promethazine in human liver microsomes. Pharmacogenetics.1996; 6: 449–457.
7.
SpigsetOGranbergKHaggSNorstromADahlqvistR. Relationship between fluvoxamine pharmacokinetics and CYP2D6/CYP2C10 phenotype polymorphisms. European Journal of Clinical Pharmacology.1997; 52: 129–133.
8.
D'ArrigoCMigliardiGSantoroVMorganteL. Effect of fluvoxamine on plasma risperidone concentrations in patients with schizophrenia. Pharmacological Research.2005; 52: 497–501.
9.
SkrobikYKBergeronNDumontMGottfriedSB. Olanzapine vs haloperidol: treating delirium in a critical care setting. Intensive Care Medicine.2004; 30: 444–449.
10.
BymasterFPCalligaroDOFalconeJFMarshRD. Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology.1996; 14: 87–96.
11.
LimCTrevinoCTampiR. Can olanzapine cause delirium in the elderly?. Annals of Pharmacotherapy.2006; 40: 135–138.
12.
KuboNShirakawaOKunoTTanakaC. Antimuscarinic effects of antihistamines: quantitative evaluation by receptor binding assay. Japanese Journal of Pharmacology.1987; 43: 277–282.
13.
MolimardMDiquetBBenedettiMS. Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans. Fundamental and Clinical Pharmacology.2004; 18: 399–411.
14.
BeaverKMGavinTJ. Treatment of acute anticholinergic poisoning with physostigmine. The American Journal of Emergency Medicine.1998; 16: 505–507.
15.
KatzRRosenthalM. Adverse interaction of cyproheptadine with serotonergic antidepressants. Journal of Clinical Psychiatry.1994; 55: 314–315.
16.
DuvoisinRCKatzR. Reversal of central anticholinergic syndrome in man by physostigmine. Journal of the American Medical Association.1968; 206: 1963.
17.
CleghornGBourkeG. Physostigmine for Promethazine poisoning. The Lancet.1980; 316: 368–369.
18.
StewartG. Convulsions after physostigmine. Anaesthesia and Intensive Care.1979; 7: 283.
19.
PentelPPetersonC. Asystole complicating physostigmine treatment of tricyclic antidepressant overdose. Annals of Emergency Medicine.1980; 9: 588–590.
20.
NoyanMElbiHAksuH. Donepezil for anticholinergic drug intoxication: A case report. Progress in Neuro-Psychopharmacology and Biological Psychiatry.2003; 27: 885–887.
